Galina Selivanova - Search Results

Year	Number of Results
2002	6
2003	2
2004	3
2005	4
2006	2
2007	2
2008	2
2009	6
2010	3
2011	4
2012	2
2013	1
2014	2
2015	1
2017	3
2018	2
2019	5
2020	6
2021	3
2022	4
2023	1
2024	1

1

Translating p53-based therapies for cancer into the clinic.

Peuget S, Zhou X, Selivanova G. Peuget S, et al. Among authors: selivanova g. Nat Rev Cancer. 2024 Mar;24(3):192-215. doi: 10.1038/s41568-023-00658-3. Epub 2024 Jan 29. Nat Rev Cancer. 2024. PMID: 38287107 Review.

2

MDM2-PROTAC versus MDM2 Inhibitors: Beyond p53 Reactivation.

Peuget S, Selivanova G. Peuget S, et al. Among authors: selivanova g. Cancer Discov. 2023 May 4;13(5):1043-1045. doi: 10.1158/2159-8290.CD-23-0229. Cancer Discov. 2023. PMID: 37139722

3

Pharmacologic Activation of p53 Triggers Viral Mimicry Response Thereby Abolishing Tumor Immune Evasion and Promoting Antitumor Immunity.

Zhou X, Singh M, Sanz Santos G, Guerlavais V, Carvajal LA, Aivado M, Zhan Y, Oliveira MMS, Westerberg LS, Annis DA, Johnsen JI, Selivanova G. Zhou X, et al. Among authors: selivanova g. Cancer Discov. 2021 Dec 1;11(12):3090-3105. doi: 10.1158/2159-8290.CD-20-1741. Cancer Discov. 2021. PMID: 34230007 Free PMC article.

4

p53: fighting cancer.

Selivanova G. Selivanova G. Curr Cancer Drug Targets. 2004 Aug;4(5):385-402. doi: 10.2174/1568009043332934. Curr Cancer Drug Targets. 2004. PMID: 15320716 Review.

5

Mutant p53 gain of function mediates cancer immune escape that is counteracted by APR-246.

Zhou X, Santos GS, Zhan Y, Oliveira MMS, Rezaei S, Singh M, Peuget S, Westerberg LS, Johnsen JI, Selivanova G. Zhou X, et al. Among authors: selivanova g. Br J Cancer. 2022 Nov;127(11):2060-2071. doi: 10.1038/s41416-022-01971-8. Epub 2022 Sep 22. Br J Cancer. 2022. PMID: 36138076 Free PMC article.

6

Inhibition of p53 inhibitors: progress, challenges and perspectives.

Sanz G, Singh M, Peuget S, Selivanova G. Sanz G, et al. Among authors: selivanova g. J Mol Cell Biol. 2019 Jul 19;11(7):586-599. doi: 10.1093/jmcb/mjz075. J Mol Cell Biol. 2019. PMID: 31310659 Free PMC article. Review.

7

p53-Dependent Repression: DREAM or Reality?

Peuget S, Selivanova G. Peuget S, et al. Among authors: selivanova g. Cancers (Basel). 2021 Sep 28;13(19):4850. doi: 10.3390/cancers13194850. Cancers (Basel). 2021. PMID: 34638334 Free PMC article.

8

Wild type p53 reactivation: from lab bench to clinic.

Selivanova G. Selivanova G. FEBS Lett. 2014 Aug 19;588(16):2628-38. doi: 10.1016/j.febslet.2014.03.049. Epub 2014 Apr 12. FEBS Lett. 2014. PMID: 24726725 Free article. Review.

9

Therapeutic targeting of p53 by small molecules.

Selivanova G. Selivanova G. Semin Cancer Biol. 2010 Feb;20(1):46-56. doi: 10.1016/j.semcancer.2010.02.006. Epub 2010 Mar 3. Semin Cancer Biol. 2010. PMID: 20206268 Review.

10

Decreased DNA Damage and Improved p53 Specificity of RITA Analogs.

Zhan Y, Zhou X, Peuget S, Singh M, Peyser BD, Fan Z, Selivanova G. Zhan Y, et al. Among authors: selivanova g. Mol Cancer Ther. 2022 Oct 7;21(10):1524-1534. doi: 10.1158/1535-7163.MCT-22-0119. Mol Cancer Ther. 2022. PMID: 35877475 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

61 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Results by year